We selected three peripheral blood specimens submitted to our molecular pathology laboratory for testing with either the Cystic Fibrosis Genotyping Assay, a quantitative JAK2 V617F MutaQuant assay, or our laboratory-developed Fragile X syndrome assay. Here, JAK2 is linked to cystic fibrosis.